Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Functional neuroanatomy and metabolism in bipolar depression treated with quetiapine (7T fMRI-guided MRS)
2006-002006-60Phase 4Terminated
- Sponsor
- Otto von Guericke University Magdeburg
- Start
- Jun 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of quetiapine in bipolar disorder (BD), sponsored by Otto von Guericke University Magdeburg. Primary endpoints: Neuroanatomical markers of therapeutic response to quetiapine, Metabolic markers of therapeutic response to quetiapine and 1 more. Started Jun 2006; status: terminated.
02
Drugs
quetiapine
03
Conditions
bipolar disorder (BD)
Beyond the preview
Go deeper on 2006-002006-60.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002006-60.